» Articles » PMID: 6218942

Plasminogen Activator Release During Venous Stasis and Exercise As Determined by a New Specific Assay

Overview
Journal Clin Chim Acta
Specialty Biochemistry
Date 1983 Jan 24
PMID 6218942
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

A method for the specific determination of tissue plasminogen activator in plasma samples has been developed. The method is based on a recently described parabolic rate assay for tissue plasminogen activator (Rånby and Wallén, 1980) measuring plasmin activity by a chromogenic tripeptide-paranitroanilide substrate. The potential interference by plasmin inhibitors in plasma is overcome by acidification of the plasma samples to pH 4 for 15 min prior to the analysis. The baseline activity (after 10 min of rest) in 22 healthy individuals was determined to be 0.05 +/- 0.03 (SD) IU/ml (0.2 +/- 0.1 ng/ml). After venous occlusion for 10 min at 100 mm Hg the activator concentrations had increased to 1.2 +/- 1.2 (SD) IU/ml (5.2 +/- 5.2 ng/ml). Furthermore, prior to venous occlusion almost no plasmin-alpha 2-antiplasmin complex was found in the samples, whereas a pronounced increase in this complex was noted in 90% of the subjects after venous occlusion. During exercise, a gradual work-load dependent increase of tissue plasminogen activator concentration was observed. At maximal work-load the concentration was 2.3 +/- 1.9 (SD) IU/ml (9.9 +/- 8.1 ng/ml active enzyme), which after 10 min rest decreased to 26 +/- 12 (SD) % of the values at maximal work-load. In these samples only small amounts of plasmin-alpha 2-antiplasmin complex were detected, although the activator content was of the same order of magnitude as after venous occlusion.

Citing Articles

Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.

Fogari R, Preti P, Lazzari P, Corradi L, Zoppi A, Fogari E Eur J Clin Pharmacol. 2003; 59(4):271-5.

PMID: 12830340 DOI: 10.1007/s00228-003-0621-3.


Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.

Pinsky D, Liao H, Lawson C, Yan S, Chen J, Carmeliet P J Clin Invest. 1998; 102(5):919-28.

PMID: 9727060 PMC: 508957. DOI: 10.1172/JCI307.


In vivo effects of urease-producing bacteria involved with the pathogenesis of infection-induced urolithiasis on renal urokinase and sialidase activity.

Du TOIT P, van Aswegen C, Nel J, Steyn P, Ligthelm A, DU PLESSIS D Urol Res. 1995; 23(5):335-8.

PMID: 8839391 DOI: 10.1007/BF00300023.


Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients.

Gray R, Yudkin J, PATTERSON D Br Heart J. 1993; 69(3):228-32.

PMID: 8461220 PMC: 1024985. DOI: 10.1136/hrt.69.3.228.


The effect of different exercise intensities on the fibrinolytic system.

Molz A, Heyduck B, Lill H, Spanuth E, Rocker L Eur J Appl Physiol Occup Physiol. 1993; 67(4):298-304.

PMID: 8299595 DOI: 10.1007/BF00357626.